Seller record · Telehealth service
Eclipse Medical Wellness
Fails 2 of 8 criteria. S5, analytical documentation: No certificate of analysis or lot document is published on the medications page, the medication cost page or the pricing page. 1 more criterion also fails; see the table below.
At a glance
Eclipse Medical WellnessTelehealth service
- Price
- Care plans $149 or $99 a month, or $500 for a three-month starter program; compounded semaglutide $249 a month from the pharmacy
- Sells
- compounded semaglutide, compounded tirzepatide, Zepbound, and 8 more
- FDA letters
- None on file
Telehealth service. Passes 6 of 8 criteria. Recorded against Standard v1.1.
A Denver-based telehealth practice for Colorado residents, led by a family nurse practitioner, that offers virtual urgent care and a medical weight loss program with labs, prescribing brand GLP-1 medications or compounded semaglutide and tirzepatide filled by an outside pharmacy.
Operating entity No legal entity name appears in the footer, on the about page or on the contact page, and the site has no terms or privacy policy.
Dispositions
| Code | Criterion | Disposition | Where it appears |
|---|---|---|---|
| S1 | Prescriber requirement | PASS | Eclipse Medical Wellness' medications page; Eclipse Medical Wellness' about page |
| S2 | Prescription gating | PASS | Eclipse Medical Wellness' pricing page; Eclipse Medical Wellness' medications page |
| S3 | Pharmacy identification | PASS | Eclipse Medical Wellness' copy of medications page |
| S4 | Compounding disclosure | PASS | Eclipse Medical Wellness' copy of medications page |
| S5 | Analytical documentation | FAIL | Eclipse Medical Wellness' medications page; Eclipse Medical Wellness' copy of medications page; Eclipse Medical Wellness' pricing page |
| S6 | Business address | FAIL | Eclipse Medical Wellness' contact page; Eclipse Medical Wellness' website |
| S7 | Price disclosure | PASS | Eclipse Medical Wellness' pricing page; Eclipse Medical Wellness' copy of medications page |
| S8 | Enforcement status | PASS | FDA warning-letter index |
Evidence, criterion by criterion
The evidence behind each disposition in the table above, where it appears, and its date.
Products shown on the seller's own pages at the recorded date: compounded semaglutide, compounded tirzepatide, Zepbound, Wegovy, Saxenda, Contrave, Foundayo, Rybelsus, orlistat, metformin, topiramate.
Other sellers of the same products
Who sells semaglutideWho sells tirzepatideWho sells liraglutide
Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.